Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Dermatologic 1

Conditions

Chondrosarcoma 1Carcinoma, Basal Cell 1

Interventions

regorafenib 1apatinib 1Standard of Care 1Proton Therapy 1Pentetic Acid 1Palliative Care 1Nutritional Support 1Minocycline 1IPI-926 1Heparin 1Glutamine 1Gelclair 1Celecoxib 1Analgesia 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Chondrosarcoma × IPI-926 × Clear all
NCT01609179 2012-11-14

IPI-926 Extension Protocol for Continuation of Treatment With IPI-926

Infinity Pharmaceuticals, Inc.

Phase NA Completed
9 enrolled
DermatologicSarcoma

Carcinoma, Basal Cell, Chondrosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡